Colorectal cancer rates rising in young adults
11/06/2014

While colorectal cancer rates are falling in people aged 50 and older, a new study has found that incidence is increasing among people aged 20-49, and could rise further.

Breast cancer survivors benefit from exercise therapy, acupuncture
11/06/2014

Two new studies from the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania offer hope for breast cancer survivors struggling with cancer-related pain and...

More childhood cancer survivors prompted to get recommended heart screenings by practice nurse brief telephone counseling
11/06/2014

Supplementing written heart screening guidelines with telephone counseling from specially trained nurses more than doubled the likelihood that adult survivors of childhood cancer received recommended...

Billions in health care savings possible with biosimilar drugs
11/06/2014

Introducing competing "biosimilar" versions of complex biologic drugs used to treat illnesses such as cancer and rheumatoid arthritis could cut spending on biologics in the United States by $44...

A reduced risk of certain cancers may be conferred on those with lactose intolerance
11/06/2014

People with lactose intolerance are at lower risk of suffering from lung, breast and ovarian cancers, according to a new study by researchers at Lund University and Region Skåne in Sweden.

Management of hot flushes following breast cancer treatment
11/06/2014

Hot flushes are one of the most distressing conditions faced by women who have been treated for breast cancer, but they are not being adequately addressed by healthcare professionals and some women...

Centralization improves care processes for breast reconstruction
11/06/2014

After opening a comprehensive breast center (CBC), one hospital achieved significant improvement in key measures of quality of care for women undergoing breast reconstruction, reports the November...

FDA study of Medicare patients reaffirms safety and efficacy profile of Pradaxa® (dabigatran etexilate mesylate) for NVAF
11/05/2014

A U.S. Food and Drug Administration (FDA) study of more than 134,000 Medicare patients found that Pradaxa® (dabigatran etexilate mesylate) was associated with significantly reduced risks of...

Campaign to cut work cancer deaths launched
11/05/2014

According to conservative estimates, some 8,000 people die from cancer and around 14,000 contract the disease each year in the UK because of exposure to a work-related carcinogen, such as diesel...

Scientists uncover potential drug to tackle 'undruggable' fault in third of cancers
11/05/2014

Scientists have found a possible way to halt one of the most common faults in many types of cancer, according to research presented at the National Cancer Research Institute (NCRI) Cancer...